Enhancing Skin Cancer Early Detection and Treatment in Primary Care

Cutaneous Melanoma Clinical Trial

Official title:

Enhancing Skin Cancer Early Detection and Treatment in Primary Care

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05675709
• Other study ID #: STUDY00024809
• Secondary ID: NCI-2022-09484ST
• Status: Enrolling by invitation
• Phase: N/A
• Start date: April 25, 2023
• Est. completion date: December 30, 2024

Study information

• Verified date: April 2024
• Source: OHSU Knight Cancer Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Skin cancer screening may help find melanoma sooner, when it may be easier to treat. If found early melanoma and other types of skin cancer may be curable. Multi-component education may be an effective method to help primary care physicians (PCPs) learn about skin cancer screening. This clinical trial examines whether a clinician-focused educational intervention can improve PCP's knowledge and clinical performance to identify and triage skin cancer. This intervention may increase the PCP's ability to diagnose, treat and/or triage early-stage melanoma.

Description:

PRIMARY OBJECTIVE:

I. Evaluate whether a multi-component education strategy improves the ability of PCPs to identify and triage skin cancer.

OUTLINE:

Participants are assigned to 1 of 2 groups.

PCP participants complete group training and online training sessions. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview.

PCPs at the two clinics who are in pods that are not assigned to receive the intervention will serve as study comparators. Comparison group has no direct exposure to the group or online training sessions.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 80
• Est. completion date: December 30, 2024
• Est. primary completion date: June 30, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Two Oregon Health & Science University (OHSU) primary care pods at two clinics will be assigned to receive exposure to the melanoma early detection intervention

• Clinicians at the two clinics who are in pods that are not assigned to receive the intervention will serve as study comparators

• These individuals are all aged 18 years or older

• All practice members speak English

Exclusion Criteria:

• No one will be intentionally excluded

Related Conditions & MeSH terms

• Cutaneous Melanoma
• Skin Neoplasms

Intervention

Behavioral:
• Training and Education
Undergo group and online trainings

Locations

Country	Name	City	State
United States	OHSU Knight Cancer Institute	Portland	Oregon

Sponsors (3)

Lead Sponsor	Collaborator
OHSU Knight Cancer Institute	National Cancer Institute (NCI), Oregon Health and Science University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reach of the educational intervention	Measured by proportion of clinicians invited to participate in the educational intervention that complete the training modules and utilize dot phases and smart tools in EHR	6 months
Primary	Clinician knowledge in screening for skin cancer	Change in knowledge based upon survey questions prior to training and post-training.	6 months
Primary	Use of risk assessment tool	Measured through electronic health record (EHR) data.	18 months
Secondary	Identification of suspicious lesions	Measured through EHR data.	18 months